Lemtrada

Lemtrada
Generic Name: alemtuzumab (AL em TOOZ ue mab)
Brand Name: Campath, Lemtrada
Company: Genzyme
FDA Approved: Nov 14, 2014
Rated: 5.9/10

Lemtrada is used to treat chronic B-cell lymphocytic leukemia or relapsing forms of multiple sclerosis.

Lemtrada is available only from a certified pharmacy under a special program.

How is Lemtrada given?
Lemtrada is given as an infusion into a vein. A healthcare provider will give you this injection.

Lemtrada must be given slowly, and the infusion can take 2 to 4 hours to complete.

You will be watched closely for at least 2 hours after receiving Lemtrada, to make sure you do not have a serious reaction.

You may be given other medicines to help prevent certain side effects. Take these medicines for the full prescribed length of time.

Lemtrada affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.

Lemtrada can have long lasting effects on your body. You may need medical tests for up to 4 years after you stop using this medicine.
Important Information
Lemtrada can cause life-threatening side effects. Seek emergency medical attention if you have sudden numbness or weakness (especially on one side of the body), severe headache or neck pain, confusion, or problems with speech, vision, or balance.

Call your doctor if you have signs of other serious side effects, such as unusual bruising or bleeding, blood in your urine or vomit, swelling in your feet, fever, swollen glands, muscle aches, diarrhea, or if you feel very weak or tired.

Some side effects may occur during the injection or shortly afterward, including chest pain, trouble breathing, irregular heartbeats, or swelling in your mouth or throat. You will be watched closely for at least 2 hours after receiving Lemtrada.

Lemtrada can have long lasting effects on your body. You may need medical tests for up to 4 years after you stop using Lemtrada.